Figure 3.
CKMB blood concentration (U L−1) in control group (n = 32), stable coronary artery disease patients (SCAD, n = 28), acute coronary syndrome, nonocclusive type, patients (ACS-UA, n = 26), and acute coronary syndrome, occlusive type, patients (ACS-STEMI, n = 37) during the eight-day period of testing. CKMB blood concentrations in control, SCAD, and ACS-UA groups were in normal physiological range during the whole investigated period (between 0 and 25 U L−1). The data are presented by means ± SEM.